Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Kahraman S, Erul E, Seyyar M, Gumusay O, Bayram E, Demirel BC, Acar O, Aksoy S, Baytemur NK, Sahin E, Cabuk D, Basaran G, Paydas S, Yaren A, Guven DC, Erdogan AP, Demirci U, Yasar A, Bayoglu İV, Hizal M, Gulbagci B, Paksoy N, Davarci SE, Yilmaz F, Dogan O, Orhan SO, Kayikcioglu E, Aytac A, Keskinkilic M, Mocan EE, Unal OU, Aydin E, Yucel H, Isik D, Eren O, Uluc BO, Ozcelik M, Hacibekiroglu I, Aydiner A, Demir H, Oksuzoglu B, Cilbir E, Cubukcu E, Cetin B, Oktay E, Erol C, Okutur SK, Yildirim N, Alkan A, Selcukbiricik F, Aksoy A, Karakas Y, Ozkanli G, Duman BB, Aydin D, Dulgar O, Er MM, Teker F, Yavuzsen T, Aykan MB, Inal A, Iriagac Y, Kalkan NO, Keser M, Sakalar T, Menekse S, Kut E, Bilgin B, Karaoglanoglu M, Sunar V, Ozdemir O, Turhal NS, Karadurmus N, Yalcin B, Nahit Sendur MA. Kahraman S, et al. Among authors: gumusay o. Future Oncol. 2023 Mar;19(10):727-736. doi: 10.2217/fon-2022-1287. Epub 2023 May 3. Future Oncol. 2023. PMID: 37133230
The DNA damaging revolution.
Cetin B, Wabl CA, Gumusay O. Cetin B, et al. Among authors: gumusay o. Crit Rev Oncol Hematol. 2020 Dec;156:103117. doi: 10.1016/j.critrevonc.2020.103117. Epub 2020 Oct 3. Crit Rev Oncol Hematol. 2020. PMID: 33059228 Review.
Immunotherapy toxicity: identification and management.
Gumusay O, Callan J, Rugo HS. Gumusay O, et al. Breast Cancer Res Treat. 2022 Feb;192(1):1-17. doi: 10.1007/s10549-021-06480-5. Epub 2022 Jan 11. Breast Cancer Res Treat. 2022. PMID: 35015209 Free PMC article. Review.
Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy.
Magbanua MJM, Gumusay O, Kurzrock R, van 't Veer LJ, Rugo HS. Magbanua MJM, et al. Among authors: gumusay o. Front Oncol. 2022 Mar 15;12:802579. doi: 10.3389/fonc.2022.802579. eCollection 2022. Front Oncol. 2022. PMID: 35372077 Free PMC article. Review.
51 results